Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1447 of 5804
-
Can CBD help heavy drinkers cut back? new study seeks answers
Disease control Recruiting nowThis is a double-blind, placebo-controlled, parallel group study designed to assess the efficacy of full spectrum CBD and broad spectrum CBD, compared to a placebo control (PC), to reduce drinking in participants with alcohol use disorder. If eligible for the study, subjects will…
Phase: PHASE2, PHASE3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New psychotherapy shows promise for insomnia in mood disorders
Symptom relief CompletedA new psychotherapy has been developed within the Psychiatry, Sleep and Chronobiology Reference Center (ChronoS) since January 2022.Results have shown relevant clinical interest on insomnia symptoms, as well on mood, anxiety and hypervigilance, according to the observation of the…
Phase: NA • Sponsor: Centre Hospitalier St Anne • Aim: Symptom relief
Last updated Jun 26, 2026 18:11 UTC
-
New group therapy aims to curb veteran suicide crisis
Symptom relief OngoingVeteran suicide death is a national crisis. Risk factors include emotion dysregulation, which occurs across mental health disorders. Dialectical behavior therapy (DBT) is an evidence-based suicide intervention that targets emotion dysregulation but is resource-intensive and not w…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Lab-Grown brain cells could unlock personalized OCD treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study focuses on people with obsessive-compulsive disorder (OCD) who do not respond well to standard treatments. Researchers aim to understand why some patients respond to medications or brain stimulation therapies, while others do not. The study will include 60 patients gro…
Phase: NA • Sponsor: ASST Fatebenefratelli Sacco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New therapy shows promise for healing war wounds in rwanda
Symptom relief CompletedThis pragmatic, pathway-stratified, cluster-randomized waitlist-controlled trial evaluated Resilience-Oriented Therapy (RoT), a culturally adapted group-based psychosocial intervention for post-genocide Rwanda. Community screening assigned eligible adults to one of three RoT vari…
Phase: NA • Sponsor: Alexandros Lordos, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New PET tracer could sharpen cancer detection
Diagnosis CompletedProspective, multi-center, open label, non-randomized clinical trial to assess efficacy of \[18F\]FAPI-74 to detect FAP expressing cells in patients diagnosed with gastrointestinal cancers, including hepatocellular carcinoma, cholangiocarcinoma, gastric, pancreatic and colorectal…
Phase: PHASE2 • Sponsor: SOFIE • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Could longer or stronger antivirals beat COVID in vulnerable patients?
Disease control Recruiting nowThe overall purpose of the trial is to evaluate the efficacy and safety of possible combination antiviral therapy DAA (remdesivir + nirmatrelvir/r)∞ versus the reference monotherapy (nirmatrelvir/r alone) and to assess the efficacy and safety of increasing the nirmatrelvir/r cour…
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New trial aims to boost COVID-19 protection for vulnerable patients
Disease control Recruiting nowThe overall purpose of the trial is to evaluate the efficacy and safety of possible combination antiviral therapy direct antiviral agents (remdesivir + nirmatrelvir/r) versus the reference monotherapy (nirmatrelvir/r alone) and to assess the efficacy and safety of increasing the …
Phase: PHASE2 • Sponsor: Calmy Alexandra • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Micro-Implant zaps nerve pain: new hope for chronic sufferers?
Symptom relief OngoingThis post market study is being conducted to document the comparative effectiveness and safety of peripheral nerve stimulation plus conventional medical management versus conventional medical management alone in the treatment of chronic, intractable peripheral neuralgia of post-t…
Phase: NA • Sponsor: Nalu Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Smartwatch could spot depression by tracking heart rate and sleep
Diagnosis OngoingObjective: Wearable technology holds promising potential for mental health monitoring and detection. Samsung has developed an algorithm that they believe can detect signs of depression and anxiety in smartwatch users. They have used this algorithm to create a "Mindfulness Index,…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC
-
New heart pump may reduce death and stroke in risky surgeries
Disease control OngoingThe purpose of this trial is to collect further data on the safety and on the effectiveness of the use of Impella 5.5® in high-risk cardiac surgery patients.
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New study tests if draining the gallbladder early prevents repeat attacks in frail patients
Disease control Recruiting nowObjectives Acute cholecystitis commonly occurs in elderly patients who are at high-risk for surgery. Whether upfront Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is advantageous over antibiotics first for mild acute cholecystitis is uncertain. Hypothesis to be tes…
Phase: PHASE3 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for advanced prostate cancer? early trial tests targeted combo therapy
Disease control Recruiting nowThe purpose of this study is to identify the recommended phase 2 regimen(s) RP2R(s) of pasritamig and combination regimens in Part 1 (dose escalation) and to determine safety at the putative RP2R(s) of pasritamig with the combination regimens in Part 2 (dose expansion).
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Autism trial tests cheap supplement for stubborn symptoms
Symptom relief Recruiting nowThe goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated nutritional supplement that has shown promise for reducing symptom severity in recent small-scale t…
Phase: PHASE2, PHASE3 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Migraine crystal ball: study aims to predict treatment success
Knowledge-focused Recruiting nowBeing able to predict each patients response to a specific treatment can mean a significant improvement in socioeconomic costs, but above all in their quality of life. With the present study, the investigators aim to analyze in a combined way different clinical, biological and ne…
Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could a One-Time immune cell infusion help older leukemia patients avoid harsh chemo?
Disease control OngoingThis phase I trial tests the safety, side effects, and best dose of autologous anti-CD19 CAR-expressing T lymphocytes (CD19-CAR T cells) in older adults with B-cell acute lymphoblastic leukemia. Chimeric antigen receptor (CAR) T-cell therapy is a type of treatment in which a pati…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug ABBV-319 takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowB-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Follicular Lymphoma is a slow-growing type of non-Hodgkin lymphoma. Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Speedy new cell therapy shows promise for tough lymphoma
Disease control OngoingThis study seeks to determine the safety and efficacy of the infusion of autologous CD19 CAR-T cells that are manufactured using an ultra-fast process.
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can baking soda save kidneys in the ICU? new trial aims to find out
Disease control OngoingThis trial aims to assess if, among adults in the ICU with metabolic acidosis, an infusion of sodium bicarbonate diluted in 5% dextrose, compared with an infusion of 5% dextrose, reduces Major Adverse Kidney Events within 30 days of randomization.
Phase: PHASE3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for tough lung cancers: triple therapy trial targets progression
Disease control OngoingThis is an open-label, randomized, non-comparative, multicentre, phase II study in which NSCLC patients who have progressed following chemotherapy and immunoptherapy are randomized to receive treatment with either paclitaxel and bevacizumab (Arm A), or paclitaxel, bevacizumab and…
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC